Literature DB >> 26938342

Corneal Haze Following Refractive Surgery: A Review of Pathophysiology, Incidence, Prevention, and Treatment.

Jordan A Margo, Wuqaas M Munir.   

Abstract

Mesh:

Year:  2016        PMID: 26938342     DOI: 10.1097/IIO.0000000000000112

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  5 in total

1.  Tranilast inhibits TGF-β-induced collagen gel contraction mediated by human corneal fibroblasts.

Authors:  Ye Liu; Xiao-Jing Zhao; Xiao-Shuo Zheng; Hui Zheng; Lei Liu; Ling-Bin Meng; Qin Li; Yang Liu
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

2.  Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper.

Authors:  Mark D Mifflin; Brent S Betts; P Adam Frederick; Jason M Feuerman; Carlton R Fenzl; Majid Moshirfar; Brian Zaugg
Journal:  Clin Ophthalmol       Date:  2017-06-12

3.  Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo.

Authors:  Suneel Gupta; Jason T Rodier; Ajay Sharma; Elizabeth A Giuliano; Prashant R Sinha; Nathan P Hesemann; Arkasubhra Ghosh; Rajiv R Mohan
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

4.  Comparison of single-step transepithelial photorefractive keratectomy and conventional photorefractive keratectomy in low to high myopic eyes.

Authors:  Aruna Kumari Gadde; Arjun Srirampur; Kavya Reddy Katta; Tarannum Mansoori; Seth Mensah Armah
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

5.  Efficacy and safety of single-step transepithelial photorefractive keratectomy with the all-surface laser ablation SCHWIND platform without mitomycin-C for high myopia: A retrospective study of 69 eyes.

Authors:  Jean Baptiste Giral; Florian Bloch; Maxime Sot; Yinka Zevering; Arpine El Nar; Jean Charles Vermion; Christophe Goetz; Louis Lhuillier; Jean-Marc Perone
Journal:  PLoS One       Date:  2021-12-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.